-
Mashup Score: 0Q&A: Retiring head of ABIM reflects on accomplishments, lessons learned during tenure - 1 year(s) ago
Richard J. Baron, MD, MACP, president and CEO of the ABIM, announced he would be retiring from his role in September 2024.“It has been an incredible privilege to lead this storied organization at such an important and transformative time,” Baron, who has served as CEO since 2013, said in a statement.
Source: www.healio.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
HRS is committed to lifelong continuous learning with immediate (formative) assessments rather than periodic “high stakes” summative examinations that cover the full breadth of the field of electrophysiology.
Source: www.hrsonline.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
great job @HRSonline . It is time for @ASH_hematology , @ASCO and @ASTCT to stand up for what is right. https://t.co/dmkl4ITaaf
-
-
Mashup Score: 7A Case of Fetal-Induced Graft-versus-Host Disease | NEJM - 2 year(s) ago
Correspondence from The New England Journal of Medicine — A Case of Fetal-Induced Graft-versus-Host Disease
Source: www.nejm.orgCategories: Latest Headlines, Partners & KOLsTweet-
RT @aksinghmd: Baby vs Mom disease !!! A Case of Fetal-Induced Graft-versus-Host Disease | NEJM https://t.co/ElFdVcpMyL
-
Baby vs Mom disease !!! A Case of Fetal-Induced Graft-versus-Host Disease | NEJM https://t.co/ElFdVcpMyL
-
-
Mashup Score: 0
Hematopoietic cell transplantation (HCT) is curative for hematologic disorders, but outcomes are historically inferior when using HLA-mismatched donors. Despite unrelated donor registries listing > 38 million volunteers, 25%-80% of US patients …
Source: PubMed Central (PMC)Categories: Hem/Oncs, Latest HeadlinesTweet-
@LoriMuffly @sghmd @drkomanduri @DrMonzrAlMalki @ASTCT @Chrislemieux90 @DrMiguelPerales I would go with the best MMUD donor available as long as 4-6/8 match. Youngest would be the best but can follow the criteria in this paper . https://t.co/BMOXYsI4FY
-
-
Mashup Score: 0Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma - Leukemia - 2 year(s) ago
Anti-PD-1 monoclonal antibodies yield high response rates in patients with relapsed/refractory classic Hodgkin lymphoma (cHL), but most patients will eventually progress. Allogeneic hematopoietic cell transplantation (alloHCT) after PD-1 blockade may be associated with increased toxicity, raising challenging questions about the role, timing, and optimal method of transplantation in this setting….
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
@BldCancerDoc I would go with RIC haplo with PTCy. Merryman et al study ( agree, retrospective ) data showed 2 yr OS of 82% . 92% patients has RIC/ NMA conditioning . https://t.co/cTpeVehHMw
-
-
Mashup Score: 0Use of Prognostic Models in Allogeneic Transplants: A Perspective Guide for Clinicians and Investigators - 2 year(s) ago
Allogeneic hematopoietic cell transplantation (HCT) can cure many hematologic diseases, but it carries the potential risks of increased morbidity and mortality
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
really enjoyed this nuanced and comprehensive take on use of prognostic models in Allogeneic transplants by Dr @msorror @BloodJournal https://t.co/veULsl9NRk
-
-
Mashup Score: 0
Raghavan Iyer, whose books and spirited teaching spread the cuisine, is using his last days to get familiar comfort foods to patients like himself.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet-
What a heart-warming and inspiring story https://t.co/Lh3V6CLWI6
-
-
Mashup Score: 0A Good Walk Spoiled | Revisionist History - 2 year(s) ago
Rich people and their addiction to golf: a philosophical investigation.
Source: Pushkin IndustriesCategories: Hem/Oncs, Latest HeadlinesTweet-
Agree. @Gladwell did a must listen podcast on everything that is wrong with golf courses holding prime land which could find better use for the public. https://t.co/lLCBKPHLLS https://t.co/Qniukz0kPV
-
-
Mashup Score: 0How I Treat Cytopenias after CAR T-cell Therapy - 2 year(s) ago
Increasing use of chimeric antigen receptor T-cell therapy (CAR-T) has unveiled diverse toxicities warranting specific recognition and management. Cytopenias oc
Source: American Society of HematologyCategories: Hematologists1, Latest HeadlinesTweet-
Nice review on cytopenia after CAR-T cell therapy by @TaniaJain11 and @DrFredLocke . How I Treat Cytopenias after CAR T-cell Therapy https://t.co/KOtibhaCUf
-
-
Mashup Score: 0Patrick Mahomes Is Not a Kid Anymore. (He Just Plays Like One.) - 2 year(s) ago
Mahomes, known for his sense of fun and improvisation on the field, has become a kind of elder statesman, settled in his family life, his business endeavors and his community.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Great article on @PatrickMahomes and his efforts outside the football field in KC. Go @Chiefs !!! . Patrick Mahomes Is Not a Kid Anymore. (He Just Plays Like One.) https://t.co/lwuvc9zSNC
-
Hope they paid @GoHealio handsomely for these softball questions . Hard to find anyone in medicine so much despised by the people he claims to represent . Hope 10 million $ was worth it , Dr. Baron. https://t.co/onuDEC0301